W. R. Berkley Corporation · WRB · FY2026 Q1 · Calendar Q2 2026

W.R. Berkley Q1 2026: record operating income, combined ratio 90.7%

W.R. Berkley's Q1 2026 shows a fundamentally sound underwriting franchise: record net investment income of $404M, a calendar-year combined ratio of 90.7%, ROE above 21% and an all-time-low capital leverage of 22.6%. Together these support continued earnings growth and generous capital returns. Management is pivoting from aggressive rate increases toward growth in margin-rich lines (casualty, professional liability, umbrella) to defend margins as competition from national carriers, Lloyd's and MGAs intensifies.

Reported After market closeNYSEFinancial Services $25.05B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $1.30 Consensus $1.13
EPS surprise +15.0% Reported versus consensus
Reported revenue $3.12B Consensus $3.19B
Revenue surprise -2.4% Reported versus consensus

Market reaction

event-close to next-session close
Stock move +3.2% Event window
SPY move +1.0% Same window
Abnormal move +2.2% Stock minus SPY
Volume 2.3× Versus trailing sessions
Subsequent drift +1.1% Up to 20 sessions
WRBSPY benchmark

Ask FN2 about WRB FY2026 Q1

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

After a record Q4 2025, W.R. Berkley delivered Q1 2026 net income of $515M and record operating income driven by strong investment results and underwriting profit. Investment portfolio net income hit a record $404M on a 4.7% book yield with new-money rates above 5%, capital leverage fell to an all-time low of 22.6%, and the calendar-year combined ratio was 90.7%. The market reaction was positive: the shares rose about 3.2% from event close to next-session close versus a benchmark gain of about 1.0%, an abnormal move of roughly +2.2%, with volume near 2.3x baseline.

Guidance delta

No formal forward guidance was provided on the call; the transcript's guidance_sentiment is not_provided, so no updated EPS or revenue outlook is available.

Key takeaways

  • Q1 net income of $515M and record operating income on strong investment results and underwriting profit.
  • Calendar-year combined ratio of 90.7% with loss ratios stable despite heightened competition.
  • Record portfolio net investment income of $404M with a 4.7% book yield and new-money rate above 5%.
  • Capital leverage at an all-time low of 22.6%, supporting buybacks and future dividends.
  • Strategic shift toward growth in margin-rich lines rather than aggressive rate hikes amid rising competition.

Management priorities

  • Continue cycle-management discipline while balancing rate and growth levers.
  • Maintain expense ratio below 30% and monitor leverage flexibility.
  • Scale contributions from Berkley Edge and Berkley Embedded.
  • Pursue growth in niche liability and professional lines where margins remain attractive.

Follow WRB with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
WRB EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 4 future estimate-only quarters. Q1 '24 estimate $1.43 Q1 '24 actual $1.04, miss Q2 '24 estimate $0.92 Q2 '24 actual $1.04, beat Q3 '24 estimate $0.92 Q3 '24 actual $0.93, match Q2 '25 estimate $1.03 Q2 '25 actual $1.05, beat Q3 '25 estimate $1.11 Q3 '25 actual $1.10, match Q4 '25 estimate $1.13 Q4 '25 actual $1.13, match Q1 '26 estimate $1.13 Q1 '26 actual $1.30, beat Q2 '26 estimate $1.08 Q2 '26 actual $1.27, beat Q3 '26 estimate $1.12 Q4 '26 estimate $1.21 Q1 '27 estimate $1.22 Q2 '27 estimate $1.18
Show 1 more >

Analyst Consensus ?

ConsensusHold30 ratings
Bullish723.3%
Neutral1756.7%
Bearish620.0%

Analyst 52W Price Targets

$66.82Current
$53.36Low
$69.3Average
$89High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 26, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Mizuho Neutral NeutralMaintainSep 16, 2026
UBS Neutral NeutralMaintainJul 27, 2026
Wells Fargo Underweight UnderweightMaintainJul 21, 2026
Truist Securities Buy BuyMaintainJul 21, 2026
B of A Securities Underperform NeutralDowngradeJul 16, 2026
Evercore ISI Group Underperform UnderperformMaintainJul 10, 2026
Cantor Fitzgerald Neutral NeutralMaintainJul 9, 2026
Keefe, Bruyette & Woods Market Perform Market PerformMaintainJul 8, 2026
Morgan Stanley Equal Weight Equal WeightMaintainJul 6, 2026
Barclays Underweight UnderweightMaintainJun 12, 2026
Goldman Sachs Buy NeutralUpgradeJun 8, 2026
Argus Research Hold BuyDowngradeApr 27, 2026
BMO Capital Market Perform UnderperformUpgradeApr 23, 2026
Jefferies Hold HoldMaintainJan 27, 2026
TD Cowen Sell HoldDowngradeJan 20, 2026
RBC Capital Sector Perform Sector PerformMaintainJan 28, 2025
Janney Montgomery Scott Buy BuyMaintainNov 11, 2022
Boenning & Scattergood Outperform NeutralUpgradeSep 20, 2021
Deutsche Bank Hold HoldMaintainApr 21, 2021
Credit Suisse Outperform OutperformMaintainJan 11, 2021
CFRA Hold HoldMaintainApr 24, 2020
Buckingham Research Buy NeutralUpgradeJan 22, 2020
Buckingham Buy NeutralUpgradeJan 22, 2020
Bank of America Underperform NeutralDowngradeJun 14, 2018
Sterne Agee CRT Neutral NeutralMaintainSep 21, 2015
Keefe Bruyette & Woods Market Perform Market PerformMaintainOct 27, 2014
Compass Point Neutral NeutralMaintainOct 27, 2014
Macquarie Neutral NeutralMaintainOct 16, 2013
Citigroup Neutral NeutralMaintainOct 12, 2012
BGB Securities Hold BuyDowngradeApr 25, 2012
Show less

Named analyst price targets

Upside is calculated against the persisted current price $66.82. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
UBSAnalyst unavailable$77$75.61 +15.2%Jul 27, 2026
Mizuho SecuritiesAnalyst unavailable$74$72.71 +10.7%Jul 21, 2026
OppenheimerAnalyst unavailable$70$72.71 +4.8%Jul 21, 2026
Atlantic EquitiesAnalyst unavailable$74$70.68 +10.7%Jul 15, 2026
Evercore ISIAnalyst unavailable$68$72.02 +1.8%Jul 10, 2026
Cantor FitzgeraldAnalyst unavailable$74$71.28 +10.7%Jul 9, 2026
Mizuho SecuritiesYaron Kinar$72$71.28 +7.8%Jul 9, 2026
BarclaysAlex Scott$62$67.54 -7.2%Jun 12, 2026
Wells FargoAnalyst unavailable$58$68.57 -13.2%Jun 8, 2026
UBSAnalyst unavailable$68$66.64 +1.8%Apr 27, 2026
BMO CapitalAnalyst unavailable$68$67.5 +1.8%Apr 23, 2026
Cantor FitzgeraldRyan Tunis$71$67.21 +6.3%Apr 9, 2026
Cantor FitzgeraldRyan Tunis$75$67.87 +12.2%Feb 2, 2026
UBSAnalyst unavailable$71$68.58 +6.3%Feb 2, 2026
Morgan StanleyAnalyst unavailable$73$67.5 +9.2%Jan 28, 2026
Truist FinancialAnalyst unavailable$80$67.09 +19.7%Jan 27, 2026
Cantor FitzgeraldAnalyst unavailable$76$69.6 +13.7%Jan 14, 2026
Mizuho SecuritiesYaron Kinar$69$68 +3.3%Jan 14, 2026
Wells FargoAnalyst unavailable$68$68.71 +1.8%Jan 13, 2026
BarclaysAlex Scott$64$69.29 -4.2%Jan 8, 2026
Goldman SachsAnalyst unavailable$73$68.49 +9.2%Jan 7, 2026
Evercore ISIAnalyst unavailable$69$69.99 +3.3%Jan 7, 2026
Morgan StanleyAnalyst unavailable$75$69.1 +12.2%Dec 16, 2025
Mizuho SecuritiesAnalyst unavailable$67$69.1 +0.3%Dec 15, 2025
Morgan StanleyAnalyst unavailable$80$77.51 +19.7%Nov 17, 2025
Cantor FitzgeraldAnalyst unavailable$78$75.1 +16.7%Oct 27, 2025
BMO CapitalAnalyst unavailable$64$75 -4.2%Oct 22, 2025
Truist FinancialAnalyst unavailable$84$73.48 +25.7%Oct 21, 2025
Wells FargoElyse Greenspan$66$73.48 -1.2%Oct 21, 2025
JefferiesAndrew Andersen$75$73.48 +12.2%Oct 21, 2025
UBSAnalyst unavailable$87$77.77 +30.2%Oct 8, 2025
BarclaysAnalyst unavailable$73$77.77 +9.2%Oct 8, 2025
Cantor FitzgeraldRyan Tunis$82$70.01 +22.7%Aug 12, 2025
Wells FargoElyse Greenspan$70$70.85 +4.8%Apr 22, 2025
Goldman SachsRobert Cox$69$62.27 +3.3%Nov 25, 2024
CFRACatherine Seifert$67$59.13 +0.3%Oct 23, 2024
UBSBrian Meredith$69$58.53 +3.3%Oct 22, 2024
Bank of America SecuritiesJoshua Shanker$76$61.03 +13.7%Oct 22, 2024
RBC CapitalScott Heleniak$63$61.03 -5.7%Oct 22, 2024
Goldman SachsAlex Scott$61$61.03 -8.7%Oct 22, 2024
Evercore ISIDavid Motemaden$60$61.03 -10.2%Oct 22, 2024
Truist FinancialMark Hughes$68$59.28 +1.8%Oct 17, 2024
JefferiesYaron Kinar$57$57.47 -14.7%Oct 9, 2024
BarclaysAlex Scott$56$60.58 -16.2%Sep 4, 2024
Wells FargoElyse Greenspan$59$51.82 -11.7%Jul 23, 2024
Goldman SachsAlex Scott$83$78.17 +24.2%Jun 13, 2024
BMO CapitalMichael Zaremski$89$78.04 +33.2%Apr 25, 2024
RBC CapitalScott Heleniak$88$86.61 +31.7%Apr 5, 2024
Morgan StanleyAnalyst unavailable$68$67.7 +1.8%Apr 27, 2022
Morgan StanleyAnalyst unavailable$67$66.69 +0.3%Apr 25, 2022
Morgan StanleyAnalyst unavailable$44.67$71.05 -33.1%Apr 21, 2022
UBSBrian Meredith$40.93$21.72 -38.7%Jul 26, 2021
Deutsche BankPhil Stefano$53.36$34.88 -20.1%Apr 21, 2021
Show less

Track every rating change on WRB the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

W. R. Berkley Corporation functions as an insurance holding company, primarily underwriting commercial policies across the United States and globally. Its extensive operations are divided into two principal divisions: Insurance, and Reinsurance & Monoline Excess. The Insurance segment delivers a wide spectrum of commercial insurance solutions. This includes foundational coverages such as general liability, property, commercial auto, and professional liability, alongside specialized offerings like workers' compensation, environmental policies for diverse businesses, directors and officers (D&O) liability, cyber risk protection, and niche policies for fine arts and jewelry.…

Historical context

All WRB earnings

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the WRB recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-09-25T22:01:12.995452+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-25T22:01:12.992111+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-25. For educational purposes only; not investment advice.